Skip to main content
ALK-Abelló logo

ALK-Abelló — Investor Relations & Filings

Ticker · ALK ISIN · DK0061802139 LEI · 529900SGCREUZCZ7P020 CO Manufacturing
Open in API
Filings indexed 1,210 across all filing types
Latest filing 2012-12-04 Transaction in Own Shar…
Country DK Denmark
Listing CO ALK

About ALK-Abelló

https://www.alk.net

ALK-Abelló is a global, research-driven pharmaceutical company specializing in the prevention, diagnosis, and treatment of allergies. The company is a world leader in allergy immunotherapy (AIT), also known as allergy vaccination, which is a disease-modifying treatment that targets the underlying cause of the allergy rather than just the symptoms. Its portfolio includes a range of allergy treatments and services, with products such as injections, sublingual tablets, and emergency treatments for severe allergic reactions like anaphylaxis. With over a century of experience, ALK-Abelló focuses on developing pharmaceutical products to improve the quality of life for people with allergies globally.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2012
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement dated December 4, 2012, detailing transactions made under a previously initiated share buyback program (aktietilbagekøbsprogram). It explicitly lists the number of shares repurchased, the average price, and the total amount spent for specific dates (November 27 to December 3). This content directly relates to the company acquiring its own shares, which corresponds precisely to the definition of 'Transaction in Own Shares'. The code for this is POS.
2012-12-04 Danish
Transaction in Own Shares 2012
Transaction in Own Shares Classification · 99% confidence The document is explicitly titled 'Share buy-back programme – week 49/2012' and details transactions made under this program, including the number of shares bought back and the average price. This directly corresponds to the definition of reporting the company's activity regarding buying back its own shares. The filing type code 'POS' (Transaction in Own Shares) is the most appropriate classification.
2012-12-04 English
Regulatory Filings 2012
Regulatory Filings
2012-12-03 Danish
Regulatory Filings 2012
Regulatory Filings Classification · 95% confidence The document is titled "Selskabsmeddelelse nr. 26/2012" (Company Announcement no. 26/2012) and is dated December 3, 2012. It discusses the finalization of efficiency measures ('Simplify-programmet') announced previously in the interim report for the first 9 months of 2012. It details expected restructuring costs (DKK 60-70 million in 2012) and confirms the outlook for net revenue and EBITDA before special items. This type of announcement, which provides specific operational and financial updates outside of a full periodic report (like 10-K or IR), often relates to significant corporate actions or material updates that need immediate disclosure. Since it is a formal company announcement providing material financial/operational updates but is not a full report, an earnings release (ER), or a specific transaction notice (like DIV or SHA), it fits best under the general regulatory announcement category, RNS, as it is a formal disclosure to the market.
2012-12-03 English
Transaction in Own Shares 2012
Transaction in Own Shares Classification · 99% confidence The document is explicitly titled "Share buy-back programme – week 48/2012" and details the transactions made under this programme for the specified week. It reports on the company purchasing its own shares. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchase activities.
2012-11-27 English
Transaction in Own Shares 2012
Transaction in Own Shares Classification · 100% confidence The document text explicitly details transactions made under a previously announced share buyback program ('aktietilbagekøbsprogram'). It lists the number of shares repurchased, the average purchase price, and the total amount spent for specific dates (November 20th to 26th, 2012). The core subject is the company's activity regarding its own shares (share repurchase). This directly corresponds to the definition for 'Transaction in Own Shares' (POS). The document is a periodic update on this specific activity, not a general regulatory filing (RNS) or a report announcement (RPA).
2012-11-27 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.